Sites / Minneapolis Heart Institute Foundation
Is this you?

Request access for Minneapolis Heart Institute Foundation with your @mhif.org work email. Intera will contact you to verify and set up your account — nothing auto-publishes.

Request account

Minneapolis Heart Institute Foundation

Unclaimed profile

Academic Network · Minneapolis, MN · ~Unknown sites

Intera lens
ICP 3Lift (cardio sample) 0.67Recruit soph 0.14
Quality Scorecard (1–100)
Overall80Recruit60Ops88Sponsor86Ther89

Performance (observed)

Historical trials
473
Completed
268
Terminated/Withdrawn
31
Completion rate
90%
Active now
159
Phase 2
108
Phase 3
176
Realized enrollment
573,971
First study year
1988
Years active
38
Match confidence
high
Enrollment velocity (inf)
15,104

Therapeutic

Areas
Cardiovascular/Vascular research (coronary artery disease, heart failure, heart rhythm, valve disease, vascular/endovascular, women's heart health)
Specialties
Cardiovascular, Heart disease, Women's heart health
Breadth (conditions)
935
Languages
English + Spanish (detected)
States
MN (Minneapolis)

Recruitment (web observed)

Trial Finder
Yes
SEO
Y
Capability notes
43 active clinical studies; 350+ patients enrolled; cardiovascular specialist network; physician-led research

Relationships

Sponsors
Children's Oncology Group; National Cancer Institute (NCI); Abbott Medical Devices; Alliance for Clinical Trials in Oncology; Minneapolis Heart Institute Foundation; SWOG Cancer Research Network
CROs
CroiValve Limited; Rho Federal Systems Division, Inc.; Shanghai MicroPort Medical (Group) Co., Ltd.
Owner / parent
Non-profit foundation (45-year history)
Recent hiring
Y

Capacity & people

Investigators
Coordinators
CEO
Kristine Fortman, PhD
VP Clinical Ops
Lisa Tindell (Vice President, Clinical Research Operations)
VP Site Ops
Unknown
VP Recruitment
Ross Garberich, MS, MBA (Vice President, Scientific Services)

Tech & DCT

EHR
Y
eSource
Yes
Builds tech
Unknown
Tech stack
Unknown
Recruiting visible
Y

Notes

Specialty academic research foundation focused on cardiovascular research. Strong scientific reputation and publications (300+). However, limited to cardiology/vascular specialty. Does not advertise patient recruitment; emphasis is on scientific excellence. Established but academic/non-profit procurement model. Geographic limitation (Minneapolis). Low ICP fit: specialty-constrained, not recruitment-focused business model. [Validated: 5 active recruiting cardiometabolic trials on ClinicalTrials.gov.]

Recommendation features (sample indication)

Ind fit 0.78Liftability 0.67Overall80

FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.